Combivent respimat and Qvar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Combivent respimat and Qvar. Common interactions include injection site swelling among females and gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people who take Combivent respimat and Qvar have. It is created by eHealthMe based on reports of 65 people who take Combivent respimat and Qvar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

65 people who take Combivent respimat and Qvar together, and have interactions are studied.

What is Combivent respimat?

Combivent respimat has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 2,044 Combivent respimat users for its effectiveness, alternative drugs and more.

What is Qvar?

Qvar has active ingredients of beclomethasone dipropionate. It is often used in asthma. eHealthMe is studying from 15,701 Qvar users for its effectiveness, alternative drugs and more.

Number of Combivent respimat and Qvar reports submitted per year:

Common Combivent Respimat and Qvar drug interactions by gender *:

female:

Injection site swelling
Loose tooth
Mitral valve incompetence
Muscle strain
Myalgia
Nausea
Neuropathy peripheral
Oral discomfort
Oral pain
Oropharyngeal pain

male:

Gastrointestinal haemorrhage
Haemorrhage
Dysphonia
Dyspnoea exertional
Embolism
Fatigue
Fluid overload
Gastrointestinal necrosis
Haemoptysis
Hiccups

Common Combivent Respimat and Qvar drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Fall
Hypoaesthesia
Neuropathy peripheral
Pain
Pain of skin
Paraesthesia
Rash macular

40-49:

Gastrointestinal haemorrhage
Haemorrhage
Rectal haemorrhage
Haematuria
Anxiety
Contusion
Dry mouth
Dysstasia
Injection site erythema
Injection site pruritus

50-59:

Osteopenia
Osteoporosis
Oxygen saturation decreased
Pain in extremity
Quality of life decreased
Vomiting
Withdrawal syndrome
Dyspnoea
Hepatocellular carcinoma
Pain

60+:

Dyspnoea
Malaise
Haemorrhagic anaemia
Headache
Hospitalisation
Hypertension
Insomnia
Memory impairment
Nasal dryness
Radius fracture

Common conditions people have *:

Hereditary Angioedema (recurrent episodes of severe swelling): 10 people, 15.38%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 13.85%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 13.85%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 7.69%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 6.15%
Pain: 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Combivent respimat and Qvar?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Combivent respimat (2,044 reports)
Qvar (15,701 reports)